ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding ESSA Pharma Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 80 | 1 | 75 | −4 |
| Shares | 34.2M | 10.5K | 37.2M | +3.03M (+8.9%) |
| Value | $976.0M | $300.0K | $297.4M | −$678.3M (−69.5%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held ESSA Pharma Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 1,000,000 | $8.00M | 0.58% |
| MPM Oncology Impact Management LP | 683,287 | $5.47M | 0.85% |
| D. E. Shaw & Co., Inc. | 315,731 | $2.53M | 0.00% |
| Woodline Partners LP | 177,008 | $1.42M | 0.02% |
| Walleye Capital LLC | 113,444 | $908.0K | 0.03% |
| Barclays PLC | 77,300 | $618.0K | 0.00% |
| HRT Financial LP | 74,187 | $593.0K | 0.00% |
| Jefferies Group LLC | 62,502 | $500.0K | 0.01% |
| Oppenheimer & Co Inc | 47,300 | $378.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 34,828 | $279.0K | 0.00% |
| State Street Corp | 33,410 | $267.0K | 0.00% |
| Walleye Trading LLC | 27,660 | $221.0K | 0.01% |
| Nuveen Asset Management, LLC | 22,642 | $181.0K | 0.00% |
| Prelude Capital Management, LLC | 20,351 | $163.0K | 0.01% |
| California State Teachers Retirement System | 18,336 | $147.0K | 0.00% |
| Fox Run Management, L.L.C. | 11,102 | $89.0K | 0.06% |
| Values First Advisors, Inc. | 10,776 | $86.0K | 0.06% |
| Tower Research Capital LLC (TRC) | 6,890 | $55.0K | 0.00% |
| Macquarie Group Ltd | 6,106 | $49.0K | 0.00% |
Sold out (23)
Institutions that held ESSA Pharma Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| VR Adviser, LLC | 625,754 | $17.9M |
| Ally Bridge Group (NY) LLC | 363,185 | $10.4M |
| Driehaus Capital Management LLC | 348,524 | $9.96M |
| Sectoral Asset Management Inc | 331,963 | $9.48M |
| Artisan Partners Limited Partnership | 291,091 | $8.32M |
| Opaleye Management Inc. | 284,050 | $8.12M |
| Commodore Capital LP | 281,911 | $8.05M |
| Marshall Wace North America L.P. | 273,413 | $7.81M |
| Burrage Capital Management LLC | 237,442 | $6.78M |
| Acuta Capital Partners, LLC | 232,896 | $6.65M |
| Altium Capital Management LP | 213,528 | $6.10M |
| Asymmetry Capital Management, L.P. | 212,525 | $6.07M |
| Darwin Global Management, Ltd. | 208,524 | $5.96M |
| Ghost Tree Capital, LLC | 207,500 | $5.93M |
| Sio Capital Management, LLC | 148,127 | $4.23M |
| Affinity Asset Advisors, LLC | 70,000 | $2.00M |
| Pura Vida Investments, LLC | 38,803 | $1.11M |
| Commonwealth Equity Services, LLC | 29,195 | $834.0K |
| SG Americas Securities, LLC | 22,093 | $631.0K |
| Maven Securities LTD | 17,711 | $512.0K |
| Marshall Wace, LLP | 14,479 | $414.0K |
| One Wealth Advisors, LLC | 8,333 | $238.0K |
| US Bancorp | 17 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held ESSA Pharma Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Wexford Capital LP | 10,500 | $300.0K |